Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Inv. presentation

Mersana Therapeutics, Inc. (MRSN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Huber Martin H. Jr. (President, CEO) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 9,102 options to buy @ $1.26, valued at $11.5k
10/04/2023 4 Dere Willard H (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 11,011 shares @ $0
10/04/2023 4 Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 9,523 options to buy @ $1.26, valued at $12k
10/04/2023 4 Alleva Lawrence M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 14,047 options to buy @ $1.26, valued at $17.7k
10/04/2023 4 MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 15,873 shares @ $0
08/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/06/2023 4 Alleva Lawrence M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 5,391 options to buy @ $3.42, valued at $18.4k
07/06/2023 4 Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 4,477 options to buy @ $3.42, valued at $15.3k
07/06/2023 4 Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 3,654 options to buy @ $3.42, valued at $12.5k
07/06/2023 4 Dere Willard H (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 4,217 shares @ $0
07/06/2023 4 MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 6,079 shares @ $0
06/12/2023 4 Hack Andrew A. F. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 14,467 shares @ $0
Granted 18,355 options to buy @ $8.64, valued at $158.6k
06/12/2023 4 Diaz Allene M. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 14,467 shares @ $0
Granted 18,355 options to buy @ $8.64, valued at $158.6k
06/12/2023 4 Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 14,467 shares @ $0
Granted 18,355 options to buy @ $8.64, valued at $158.6k
06/12/2023 4 Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 14,467 shares @ $0
Granted 18,355 options to buy @ $8.64, valued at $158.6k
06/12/2023 4 MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 14,467 shares @ $0
Granted 18,355 options to buy @ $8.64, valued at $158.6k
06/12/2023 4 Alleva Lawrence M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 14,467 shares @ $0
Granted 18,355 options to buy @ $8.64, valued at $158.6k
06/12/2023 4 Dere Willard H (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 14,467 shares @ $0
Granted 18,355 options to buy @ $8.64, valued at $158.6k
04/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2023 4 Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 3,451 options to buy @ $4.25, valued at $14.7k
04/05/2023 4 Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 3,375 options to buy @ $4.25, valued at $14.3k
04/05/2023 4 MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 4,866 shares @ $0
04/05/2023 4 Alleva Lawrence M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 4,525 options to buy @ $4.25, valued at $19.2k
04/05/2023 4 Dere Willard H (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 3,375 shares @ $0
01/18/2023 4 Yang Arvin (SVP, Chief Medical Officer) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Sold 2,209 shares @ $5.74, valued at $12.7k
Granted 217,500 options to buy @ $6.06, valued at $1.3M
Granted 48,333 restricted stock units @ $0
Exercised 7,084 restricted stock units @ $0
01/18/2023 4 Protopapas Anna (President & CEO) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Gifted 240,244 shares @ $0
Gifted 240,244 shares @ $0
Sold 17,346 shares @ $5.74, valued at $99.6k
Granted 562,500 options to buy @ $6.06, valued at $3.4M
Granted 125,000 restricted stock units @ $0
Exercised 16,750 restricted stock units @ $0
Exercised 21,250 restricted stock units @ $0
Exercised 17,708 restricted stock units @ $0
01/18/2023 4 Mandelia Ashish (VP, Controller) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Sold 3,575 shares @ $5.74, valued at $20.5k
Granted 47,625 options to buy @ $6.06, valued at $288.6k
Granted 10,583 restricted stock units @ $0
Exercised 4,784 restricted stock units @ $0
Exercised 4,519 restricted stock units @ $0
Exercised 833 restricted stock units @ $0
01/18/2023 4 MISRA TUSHAR (SVP, CMO) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Sold 458 shares @ $5.74, valued at $2.6k
Granted 127,500 options to buy @ $6.06, valued at $772.7k
Granted 28,333 restricted stock units @ $0
Exercised 1,459 restricted stock units @ $0
01/18/2023 4 Lowinger Timothy B (SVP, Chief Sci.&Tech. Off.) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Sold 6,233 shares @ $5.74, valued at $35.8k
Granted 168,750 options to buy @ $6.06, valued at $1M
Granted 37,500 restricted stock units @ $0
Exercised 4,792 restricted stock units @ $0
Exercised 7,292 restricted stock units @ $0
Exercised 7,917 restricted stock units @ $0
01/18/2023 4 DeSchuytner Brian (SVP, CFO) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Sold 5,131 shares @ $5.74, valued at $29.5k
Granted 180,000 options to buy @ $6.06, valued at $1.1M
Granted 40,000 restricted stock units @ $0
Exercised 6,250 restricted stock units @ $0
Exercised 6,250 restricted stock units @ $0
Exercised 3,958 restricted stock units @ $0
01/18/2023 4 Carvajal Alejandra (SVP, Chief Legal Officer) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Sold 782 shares @ $5.74, valued at $4.5k
Granted 161,250 options to buy @ $6.06, valued at $977.2k
Granted 35,833 restricted stock units @ $0
Exercised 2,500 restricted stock units @ $0
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy